Bavarian Receives $25 Million Milestone Payment from U.S.

Bavarian Nordic A/S said it has received a performance-based milestone payment of $25 million under the contract with the U.S. government to deliver 20 million doses of its smallpox vaccine, IMVAMUNE.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE